Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Die Highlights vom Kongress des American College of Cardiology 2024

Im April diskutierten die Herz-Kreislauf-Spezialisten aus der ganzen Welt auf dem  Kongress des American College of Cardiology (ACC) u.a. neue Therapieansätze bei akutem Myokardinfarkt, koronarer Herzerkrankung, kardiogenem Schock oder Aortenklappenstenose. In unserem Kongress-Dossier haben wir für Sie Berichte über die „Late-Breaking Trials“ und andere wichtige Studien zusammengestellt. 
Erweiterte Suche
Anmelden
nach oben
Diabetologia
Erschienen in: Diabetologia 6/2011

01.06.2011 | Review

Environmental pollutants and type 2 diabetes: a review of mechanisms that can disrupt beta cell function

verfasst von: T. L. M. Hectors, C. Vanparys, K. van der Ven, G. A. Martens, P. G. Jorens, L. F. Van Gaal, A. Covaci, W. De Coen, R. Blust

Erschienen in: Diabetologia | Ausgabe 6/2011

Einloggen, um Zugang zu erhalten

Abstract

The prevalence of diabetes mellitus is currently at epidemic proportions and it is estimated that it will increase even further over the next decades. Although genetic predisposition and lifestyle choices are commonly accepted reasons for the occurrence of type 2 diabetes, it has recently been suggested that environmental pollutants are additional risk factors for diabetes development and this review aims to give an overview of the current evidence for this. More specifically, because of the crucial role of pancreatic beta cells in the development and progression of type 2 diabetes, the present work summarises the known effects of several compounds on beta cell function with reference to mechanistic studies that have elucidated how these compounds interfere with the insulin secreting capacity of beta cells. Oestrogenic compounds, organophosphorus compounds, persistent organic pollutants and heavy metals are discussed, and a critical reflection on the relevance of the concentrations used in mechanistic studies relative to the levels found in the human population is given. It is clear that some environmental pollutants affect pancreatic beta cell function, as both epidemiological and experimental research is accumulating. This supports the need to develop a solid and structured platform to fully explore the diabetes-inducing potential of pollutants.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zimmet P, Alberti KGMM, Shaw J (2001) Global and societal implications of the diabetes epidemic. Nature 414:782–787PubMed
2.
Bhatnagar A (2009) Could dirty air cause diabetes? Circulation 119:492–494PubMed
3.
Grün F, Blumberg B (2009) Endocrine disrupters as obesogens. Mol Cell Endocrinol 304:19–29PubMed
4.
Longnecker MP, Daniels JL (2001) Environmental contaminants as etiologic factors for diabetes. Environ Health Perspect 109(Suppl 6):871–876PubMed
5.
Alonso-Magdalena P, Ropero AB, Soriano S, Quesada I, Nadal A (2010) Bisphenol A: a new diabetogenic factor. Hormones 9:118–126PubMed
6.
Carpenter DO (2008) Environmental contaminants as risk factors for developing diabetes. Rev Environ Health 23:59–74PubMed
7.
Lin Y, Sun Z (2010) Current views on type 2 diabetes. J Endocrinol 204:1–11PubMed
8.
Kahn SE (2003) The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes. Diabetologia 46:3–19PubMed
9.
Muoio DM, Newgard CB (2008) Molecular and metabolic mechanisms of insulin resistance and β-cell failure in type 2 diabetes. Nat Rev 9:193–205
10.
Rutter GA (2001) Nutrient–secretion coupling in the pancreatic islet β-cell: recent advances. Mol Aspects Med 22:247–284PubMed
11.
Henquin JC (2000) Triggering and amplifying pathways of regulation of insulin secretion by glucose. Diabetes 49:1751–1760PubMed
12.
Jones PM, Persaud SJ (1998) Protein kinases, protein phosphorylation and the regulation of insulin secretion from pancreatic β-cells. Endocr Rev 19:429–461PubMed
13.
Schuit FC, Kiekens R, Pipeleers DG (1991) Measuring the balance between insulin synthesis and insulin release. Biochem Biophys Res Commun 178:1182–1187PubMed
14.
Martens GA, Pipeleers D (2009) Glucose, regulator of survival and phenotype of pancreatic beta cells. Vitam Horm 80:507–539PubMed
15.
Bouwens L, Rooman I (2005) Regulation of pancreatic beta-cell mass. Physiol Rev 85:1255–1270PubMed
16.
Henriksen GL, Ketchum NS, Michalek JE, Swaby JA (1997) Serum dioxin and diabetes mellitus in veterans of Operation Ranch Hand. Epidemiology 8:252–258PubMed
17.
Pesatori AC, Zocchetti C, Guercilena S, Consonni D, Turrini D, Bertazzi PA (1998) Dioxin exposure and non-malignant health effects: a mortality study. Occup Environ Med 55:126–131PubMed
18.
Cranmer M, Louie S, Kennedy RH, Hern PA, Fonseca VA (2000) Exposure to 2,3,7,8-tetranchlorodibenzo-p-dioxin (TCDD) is associated with hyperinsulinemia and insulin resistance. Toxicol Sci 56:431–436PubMed
19.
Vena J, Boffetta P, Becher H et al (1998) Exposure to dioxin and nonneoplastic mortality in the expanded IARC international cohort study of phenoxy herbicide and chlorophenol production workers and sprayers. Environ Health Perspect 106(Suppl 2):645–653PubMed
20.
Philibert A, Schwartz H, Mergler D (2009) An exploratory study of diabetes in a first nation community with respect to serum concentrations of p,p′-DDE and PCBs and fish consumption. Int J Environ Res Public Health 6:3179–3189PubMed
21.
Krämer U, Herder C, Sugiri D et al (2010) Traffic-related air pollution and incident type 2 diabetes: results from the SALIA cohort study. Environ Health Perspect 118:1273–1279PubMed
22.
Uemura H, Arisawa K, Hiyoshi M et al (2008) Associations of environmental exposure to dioxins with prevalent diabetes among general inhabitants in Japan. Environ Res 108:63–68PubMed
23.
Ukropec J, Radikova Z, Huckova M et al (2010) High prevalence of prediabetes and diabetes in a population exposed to high levels of an organochlorine cocktail. Diabetologia 53:899–906PubMed
24.
Glynn AW, Granath F, Aune M et al (2003) Organochlorines in Swedish women: determinants of serum concentrations. Environ Health Perspect 111:349–355PubMed
25.
Rignell-Hydbom A, Lidfeldt J, Kiviranta H et al (2009) Exposure to p,p′-DDE: a risk factor for type 2 diabetes. PLoS ONE 4:e7503PubMed
26.
Rylander L, Rignell-Hydbom A, Hagmar L (2005) A cross-sectional study of the association between persistent organochlorine pollutants and diabetes. Environ Health 4:28PubMed
27.
Wang S-L, Tsai P-C, Yang C-Y, Guo YL (2008) Increased risk of diabetes and polychlorinated biphenyls and dioxins: a 24-year follow-up study of the Yucheng cohort. Diab Care 31:1574–1579
28.
Codru N, Schymura MJ, Negoita S, The Akwesasne Task Force on the Environment, Rej R, Carpenter DO (2007) Diabetes in relation to serum levels of polychlorinated biphenyls and chlorinated pesticides in adult native Americans. Environ Health Perspect 115:1442–1447PubMed
29.
Cox S, Niskar AS, Narayan KMV, Marcus M (2007) Prevalence of self-reported diabetes and exposure to organochlorine pesticides among Mexican Americans: Hispanic Health and Nutrition Examination Survey, 1982–1984. Environ Health Perspect 115:1747–1752PubMed
30.
Everett CJ, Frithsen IL, Diaz VA, Koopman RJ, Simpson WM Jr, Mainous AG 3rd (2007) Association of a polychlorinated dibenzo-p-dioxin, a polychlorinated biphenyl, and DDT with diabetes in the 1999–2002 National Health and Nutrition Examination Survey. Environ Res 103:413–418PubMed
31.
Lang IA, Galloway TS, Scarlett A et al (2008) Association of urinary bisphenol A concentration with medical disorders and laboratory abnormalities in adults. JAMA 300:1303–1310PubMed
32.
Lee D-H, Lee I-K, Song K et al (2006) A strong dose–response relation between serum concentrations of persistent organic pollutants and diabetes: results from the National Health and Examination Survey 1999–2002. Diab Care 29:1638–1644
33.
Lee D-H, Lee I-K, Steffes M, Jacobs DR Jr (2007) Extended analysis of the association between serum concentrations of persistent organic pollutants and diabetes. Diab Care 30:1596–1598
34.
Lee D-H, Steffes MW, Sjödin A, Jones RS, Needham LL, Jacobs DR Jr (2010) Low dose of some persistent organic pollutants predicts type 2 diabetes: a nested case–control study. Environ Health Perspect 118:1235–1242PubMed
35.
Lim J-S, Lee D-H, Jacobs DR Jr (2008) Association of brominated flame retardants with diabetes and metabolic syndrome in the U.S. population 2003–2004. Diab Care 31:1802–1807
36.
Montgomery MP, Kamel F, Saldana TM, Alavanja MCR, Sandler DP (2008) Incident diabetes and pesticide exposure among licensed pesticide applicators: agricultural health study, 1993–2003. Am J Epidemiol 167:1235–1246PubMed
37.
Schwartz GG, Il’yasova D, Ivanova A (2003) Urinary cadmium, impaired fasting glucose, and diabetes in the NHANES III. Diab Care 26:468–470
38.
Turyk M, Anderson HA, Knobeloch L, Imm P, Persky VW (2009) Prevalence of diabetes and body burdens of polychlorinated biphenyls, polybrominated diphenyl ethers, and p,p′-diphenyldichloroethene in Great Lakes sport fish consumers. Chemosphere 75:674–679PubMed
39.
Navas-Acien A, Silbergeld EK, Streeter RA, Clark JM, Thomas AB, Guallar E (2006) Arsenic exposure and type 2 diabetes: a systematic review of the experimental and epidemiologic evidence. Environ Health Perspect 114:641–648PubMed
40.
Heldring N, Pike A, Andersson S et al (2007) Estrogen receptors: how do they signal and what are their targets. Physiol Rev 87:905–931PubMed
41.
Chen J-Q, Brown TR, Russo J (2009) Regulation of energy metabolism pathways by estrogens and estrogenic chemicals and potential implications in obesity associated with increased exposure to endocrine disruptors. Biochim Biophys Acta 1793:1128–1143PubMed
42.
Nadal A, Alonso-Magdalena P, Soriano S, Quesada I, Ropero AB (2009) The pancreatic beta-cell as a target of estrogens and xenoestrogens: implications for blood glucose homeostasis and diabetes. Mol Cell Endocrinol 304:63–68PubMed
43.
Alonso-Magdalena P, Ropero AB, Carrera MP et al (2008) Pancreatic insulin content regulation by the estrogen receptor ERα. PLoS ONE 3:e2069PubMed
44.
Nadal A, Alonso-Magdalena P, Soriano S, Ropero AB, Quesada I (2009) The role of oestrogens in the adaptation of islets to insulin resistance. J Physiol 587:5031–5037PubMed
45.
Le May MC, Chu K, Hu M et al (2006) Estrogens protect pancreatic β-cells from apoptosis and prevent insulin-deficient diabetes mellitus in mice. Proc Natl Acad Sci USA 103:9232–9237PubMed
46.
Nadal A, Rovira JM, Laribi O et al (1998) Rapid insulinotropic effect of 17β-estradiol via a plasma membrane receptor. FASEB J 12:1341–1348PubMed
47.
Alonso-Magdalena P, Morimoto S, Ripoll C, Fuentes E, Nadal A (2006) The estrogenic effect of bisphenol A disrupts pancreatic β-cell function in vivo and induces insulin resistance. Environ Health Perspect 114:106–112PubMed
48.
Quesada I, Fuentes E, Viso-León C, Soria B, Ripoll C, Nadal A (2002) Low doses of the endocrine disrupter bisphenol-A and the native hormone 17β-estradiol rapidly activate transcription factor CREB. FASEB J 16:1671–1673PubMed
49.
Nadal A, Ropero AB, Fuentes E, Soria B, Ripoll C (2004) Estrogen and xenoestrogen actions on endocrine pancreas: from ion channel modulation to activation of nuclear function. Steroids 69:531–536PubMed
50.
Soriano S, Ropero AB, Alonso-Magdalena P et al (2009) Rapid regulation of KATP channel activity by 17β-estradiol in pancreatic β-cells involves the estrogen receptor β and the atrial natriuretic peptide receptor. Mol Endocrinol 23:1973–1982PubMed
51.
Nadal A, Ropero AB, Laribi O, Maillet M, Fuentes E, Soria B (2000) Nongenomic actions of estrogens and xenoestrogens by binding at a plasma membrane receptor unrelated to estrogen receptor α and estrogen receptor β. Proc Natl Acad Sci USA 97:11603–11608PubMed
52.
Ackermann S, Hiller S, Osswald H, Losle M, Grenz A, Hambrock A (2009) 17β-Estradiol modulates apoptosis in pancreatic β-cells by specific involvement of the sulfonylurea receptor (SUR) isoform SUR1. J Biol Chem 284:4905–4913PubMed
53.
Mårtensson UEA, Salehi SA, Windahl S et al (2009) Deletion of the G protein-coupled receptor 30 impairs glucose tolerance, reduces bone growth, increases blood pressure, and eliminates estradiol-stimulated insulin release in female mice. Endocrinology 150:687–698PubMed
54.
Wetherill YB, Akingbemi BT, Kanno J et al (2007) In vitro molecular mechanisms of bisphenol A action. Reprod Toxicol 24:178–198PubMed
55.
Richter CA, Birnbaum LS, Farabollini F et al (2007) In vivo effects of bisphenol A in laboratory rodent studies. Reprod Toxicol 24:199–224PubMed
56.
European Commission (2007) Commission Staff Working Document on the implementation of the “Community Strategy for Endocrine Disrupters”—a range of substances suspected of interfering with the hormone systems of humans and wildlife (COM (1999) 706), (COM (2001) 262) and (SEC (2004) 1372). SEC(2007) 1635. Commission of the European Communities, Brussels. Available from http://​ec.​europa.​eu/​environment/​endocrine/​documents/​final_​report_​2007.​pdf. Accessed 8 February 2011
57.
Welshons WV, Nagel SC, Vom Saal FS (2006) Large effects from small exposures. III. Endocrine mechanisms mediating effects of bisphenol A at levels of human exposure. Endocrinology 147:S56–S69PubMed
58.
Ghafour-Rashidi Z, Dermenaki-Farahani E, Aliahmadi A et al (2007) Protection by cAMP and cGMP phosphodiesterase inhibitors of diazinon-induced hyperglycaemia and oxidative/nitrosative stress in rat Langerhans islets cells: molecular evidence for involvement of non-cholinergic mechanisms. Pestic Biochem Physiol 87:261–270
59.
Rahimi R, Abdollahi M (2007) A review on the mechanism involved in hyperglycaemia induced by organophosphorus pesticides. Pestic Biochem Physiol 88:115–121
60.
McKinlay R, Plant JA, Bell JNB, Voulvoulis N (2008) Endocrine disrupting pesticides: implications for risk assessment. Environ Int 34:168–183PubMed
61.
Jeong SH, Kim BY, Kang HG, Ku HK, Cho JH (2006) Effect of chlorpyrifos-methyl on steroid and thyroid hormones in rat F0- and F1-generations. Toxicology 220:189–202PubMed
62.
Sahin IÇ, Onbasi K, Sahin H, Karakaya C, Ustun Y, Noyan T (2002) The prevalence of pancreatitis in organophosphate poisonings. Hum Exp Toxicol 21:175–177PubMed
63.
Roeyen G, Chapelle T, Jorens P, De Beeck BO, Ysebaert D (2008) Necrotizing pancreatitis due to poisoning with organophosphate pesticides. Acta Gastroenterol Belg 71:27–29PubMed
64.
Kamath V, Rajini PS (2007) Altered glucose homeostasis and oxidative impairment in pancreas of rats subjected to dimethoate intoxication. Toxicology 231:137–146PubMed
65.
Pournourmohammadi S, Ostad SN, Azizi E et al (2007) Induction of insulin resistance by malathion: evidence for disrupted islets cells metabolism and mitochondrial dysfunction. Pestic Biochem Physiol 88:346–352
66.
Vosough-Ghanbari S, Sayyar P, Pournourmohammadi S, Aliahmadi A, Ostad SN, Abdollahi M (2007) Stimulation of insulin and glucagon synthesis in rat Langerhans islets by malathion in vitro: evidence for mitochondrial interaction and involvement of subcellular non-cholinergic mechanisms. Pestic Biochem Physiol 89:130–136
67.
Panahi P, Vosough-Ghanbari S, Pournourmohammadi S et al (2006) Stimulatory effects of malathion on the key enzymes activities of insulin secretion in Langerhans islets, glutamate dehydrogenase and glucokinase. Toxicol Mech Methods 16:161–167PubMed
68.
Gilon P, Henquin J-P (2001) Mechanisms and physiological significance of the cholinergic control of pancreatic β-cell function. Endocr Rev 22:565–604PubMed
69.
Romero-Navarro G, Lopez-Aceves T, Rojas-Ochoa A, Fernandez Mejia C (2006) Effect of dichlorvos on hepatic and pancreatic glucokinase activity and gene expression, and on insulin mRNA levels. Life Sci 78:1015–1020PubMed
70.
Gowda H, Uppal RP (1983) Effect of malathion on adrenal activity, liver glycogen and blood glucose in rats. Indian J Med Res 78:847–851PubMed
71.
72.
Rogan WJ, Chen A (2005) Health risks and benefits of bis(4-chlorophenyl)-1,1,1-trichloroethane (DDT). Lancet 366:763–773PubMed
73.
Darras VM (2008) Endocrine disrupting polyhalogenated organic pollutants interfere with thyroid hormone signaling in the developing brain. Cerebellum 7:26–37PubMed
74.
Birnbaum LS (1995) Developmental effects of dioxins and related endocrine disrupting chemicals. Toxicol Lett 82:743–750PubMed
75.
Novelli M, Piaggi S, De Tata V (2005) 2,3,7,8-Tetrachlorodibenzo-p-dioxin-induced impairment of glucose-stimulated insulin secretion in isolated rat pancreatic islets. Toxicol Lett 156:307–314PubMed
76.
Seefeld MD, Corbett SW, Keesey RE, Peterson RE (1984) Characterization of the wasting syndrome in rats treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol Appl Pharmacol 73:311–322PubMed
77.
Enan E, Liu PCC, Matsumura F (1992) 2,3,7,8-Tetrachlorodibenzo-p-dioxin causes reduction of glucose transporting activities in the plasma membranes of adipose tissue and pancreas from the guinea pig. J Biol Chem 267:19785–19791PubMed
78.
Enan E, Liu PCC, Matsumura F (1992) TCDD causes reduction in glucose uptake through glucose transporters on the plasma membranes of the guinea pig adipocyte. J Environ Sci Health B 27:495–510PubMed
79.
Ebner K, Brewster DW, Matsumura F (1988) Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on serum insulin and glucose levels in the rabbit. J Environ Sci Health B 23:427–438PubMed
80.
Matsumura F (1995) Mechanism of action of dioxin-type chemicals, pesticides, and other xenobiotics affecting nutritional indexes. Am J Clin Nutr 61(Suppl):695S–701SPubMed
81.
Piaggi S, Novelli M, Martino L et al (2007) Cell death and impairment of glucose-stimulated insulin secretion induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in the β-cell line INS-1E. Toxicol Appl Pharmacol 220:333–340PubMed
82.
Michalek JE, Akhtar FZ, Kiel JL (1999) Serum dioxin, insulin, fasting glucose, and sex hormone-binding globulin in veterans of Operation Ranch Hand. J Clin Endocrinol Metab 84:1540–1543PubMed
83.
Lajoix AD, Reggio H, Chardès T et al (2001) A neuronal isoform of nitric oxide synthase expressed in pancreatic β-cells controls insulin secretion. Diabetes 50:1311–1323PubMed
84.
Sjöholm A (1996) Nitric oxide donor SIN-1 inhibits insulin release. Am J Physiol 271:C1098–C1102PubMed
85.
Fischer LJ, Zhou H-R, Wagner MA (1996) Polychlorinated biphenyls release insulin from RINm5F cells. Life Sci 59:2041–2049PubMed
86.
Fischer LJ, Wagner MA, Madhukar BV (1999) Potential involvement of calcium, CaM kinase II, and MAP kinases in PCB-stimulated insulin release from RINm5F cells. Toxicol Appl Pharmacol 159:194–203PubMed
87.
Chen YW, Yang CY, Huang CF, Hung DZ, Leung YM, Liu SH (2009) Heavy metals and islet function and diabetes development. Islets 1:169–176PubMed
88.
Edwards JR, Prozialeck WC (2009) Cadmium, diabetes and chronic kidney disease. Toxicol Appl Pharmacol 238:289–293PubMed
89.
Ghafghazi T, Mennear JH (1975) The inhibitory effect of cadmium on the secretory activity of the isolated perfused rat pancreas. Toxicol Appl Pharmacol 31:134–142
90.
Nilsson T, Rorsman F, Berggren PO, Hellman B (1986) Accumulation of cadmium in pancreatic β-cells is similar to that of calcium in being stimulated by both glucose and high potassium. Biochim Biophys Acta 888:270–277PubMed
91.
Lei LJ, Jin TY, Zhou YF (2007) Insulin expression in rats exposed to cadmium. Biomed Environ Sci 20:295–301PubMed
92.
Izquierdo-Vega JA, Soto CA, Sanchez-Peña LC, De Vizcaya-Ruiz A, Del Razo LM (2006) Diabetogenic effects and pancreatic oxidative damage in rats subchronically exposed to arsenite. Toxicol Lett 160:135–142PubMed
93.
Díaz-Villaseñor A, Burns AL, Hiriart M, Cebrián ME, Ostrosky-Wegman P (2007) Arsenic-induced alteration in the expression of genes related to type 2 diabetes mellitus. Toxicol Appl Pharmacol 225:123–133PubMed
94.
MacFarlane WM, Smith SB, James RF et al (1997) The p38/reactivating kinase mitogen-activated protein kinase cascade mediates the activation of the transcription factor insulin upstream factor 1 and insulin gene transcription by high glucose in pancreatic beta-cells. J Biol Chem 272:20936–20944PubMed
95.
Paul DS, Hernández-Zavala A, Walton FS et al (2007) Examination of the effects of arsenic on glucose homeostasis in cell culture and animal studies: development of a mouse model for arsenic-induced diabetes. Toxicol Appl Pharmacol 222:305–314PubMed
96.
Stanojevic V, Habener JF, Thomas MK (2004) Pancreas duodenum homeobox-1 (PDX-1) transcriptional activation requires interactions with p300. Endocrinology 145:2918–2928PubMed
97.
Díaz-Villaseñor A, Sánchez-Soto MC, Cebrián ME, Ostrosky-Wegman P, Hiriart M (2006) Sodium arsenite impairs insulin secretion and transcription in pancreatic beta-cells. Toxicol Appl Pharmacol 214:30–34PubMed
98.
Fu J, Woods CG, Yehuda-Shnaidman E et al (2010) Low level arsenic impairs glucose-stimulated insulin secretion in pancreatic β-cells: involvement of cellular adaptive response to oxidative stress. Environ Health Perspect 118:864–870PubMed
99.
Chen YW, Huang CF, Tsai KS et al (2006) Methylmercury induced pancreatic β-cell apoptosis and dysfunction. Chem Res Toxicol 19:1080–1085PubMed
100.
Chen YW, Huang CF, Tsai KS et al (2006) The role of phosphoinositide 3-kinase/Akt signaling in low-dose mercury-induced mouse pancreatic β-cell dysfunction in vitro and in vivo. Diabetes 55:1614–1624PubMed
101.
102.
vom Saal FS, Akingbemi BT, Belcher SM et al (2007) Chapel Hill bisphenol A expert panel consensus statement: integration of mechanisms, effects in animals and potential to impact human health at current levels of exposure. Reprod Toxicol 24:131–138
103.
104.
105.
US Environmental Protection Agency (U.S. EPA) (2010) EPA’s reanalysis of key issues related to dioxin toxicity and response to nas comments (external review draft). US Environmental Protection Agency, Washington, EPA/600/R-10/038A
106.
107.
Calafat AM, Kuklenyik Z, Reidy JA et al (2005) Urinary concentrations of bisphenol A and 4-nonylphenol in a human reference population. Environ Health Perspect 113:391–395PubMed
108.
109.
Agency for Toxic Substances and Disease Registry (ATSDR) (2008) Toxicological profile for cadmium (Draft for public comment). US Department of Health and Human Services, Public Health Service, Atlanta
110.
Holson JF, Stump DG, Clevidence KJ, Knapp JF, Farr CH (2000) Evaluation of the prenatal developmental toxicity of orally administered arsenic trioxide in rats. Food Chem Toxicol 38:459–466PubMed
Metadaten
Titel
Environmental pollutants and type 2 diabetes: a review of mechanisms that can disrupt beta cell function
verfasst von
T. L. M. Hectors
C. Vanparys
K. van der Ven
G. A. Martens
P. G. Jorens
L. F. Van Gaal
A. Covaci
W. De Coen
R. Blust
Publikationsdatum
01.06.2011
Verlag
Springer-Verlag
Erschienen in
Diabetologia / Ausgabe 6/2011
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-011-2109-5

Weitere Artikel der Ausgabe 6/2011

Diabetologia 6/2011 Zur Ausgabe

Commentary

Peroxisome proliferator-activated receptor γ coactivator 1β (PGC-1β) improves skeletal muscle mitochondrial function and insulin sensitivity

Article

Serum cystatin C and the incidence of type 2 diabetes mellitus

Commentary

Angiotensin receptor blockade in diabetic women of childbearing potential: an acceptable risk?

Article

Myostatin-deficient mice exhibit reduced insulin resistance through activating the AMP-activated protein kinase signalling pathway

Article

Increased mitochondrial substrate sensitivity in skeletal muscle of patients with type 2 diabetes

Article

Haemoglobin A1c levels and subsequent cardiovascular disease in persons without diabetes: a meta-analysis of prospective cohorts

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise